Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database

BACKGROUND: Pneumocystis jiroveci pneumonia (PCP) prophylaxis is recommended for patients with CD4 counts of less than 200 cells/mm(3). This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lim, Poh-Lian, Zhou, Jialun, Ditangco, Rossana A, Law, Matthew G, Sirisanthana, Thira, Kumarasamy, Nagalingeswaran, Chen, Yi-Ming A, Phanuphak, Praphan, Lee, Christopher KC, Saphonn, Vonthanak, Oka, Shinichi, Zhang, Fujie, Choi, Jun Y, Pujari, Sanjay, Kamarulzaman, Adeeba, Li, Patrick CK, Merati, Tuti P, Yunihastuti, Evy, Messerschmidt, Liesl, Sungkanuparph, Somnuek
Médium: Artigo
Jazyk:Inglês
Vydáno: The International AIDS Society 2012
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354658/
https://ncbi.nlm.nih.gov/pubmed/22281054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2652-15-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky